CDKN3 Produkte
(Cyclin-Dependent Kinase Inhibitor 3 (CDKN3))
Kategorien
The protein encoded by this gene belongs to the dual specificity protein phosphatase family. It was identified as a cyclin-dependent kinase inhibitor, and has been shown to interact with, and dephosphorylate CDK2 kinase, thus prevent the activation of CDK2 kinase. This gene was reported to be deleted, mutated, or overexpressed in several kinds of cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte CDKN3 Kategorien
CDKN3 Antikörper
High quality antibodies with extensive validation data.
CDKN3 ELISA Kits
Reliable ELISA kits for a wide range of species.
CDKN3 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene CDKN3 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
WB, ELISA, IHC, IF, ICC
Validierungen
- (4)
Kat. Nr.
ABIN6260728
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IHC, IF
Validierungen
- (3)
Kat. Nr.
ABIN3022822
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
ELISA, IHC, IF
Validierungen
- (2)
Kat. Nr.
ABIN7148919
Menge
100 μg
Datenblatt
Datenblatt
Empfohlene CDKN3 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6966182
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6955168
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human, Mouse
Analytical Method
Qualitative Cell ELISA
Validierungen
Kat. Nr.
ABIN5648167
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene CDKN3 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN7122543
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1349027
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1349026
Menge
25 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren CDKN3 Produkten
: "High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer." in: International journal of cancer. Journal international du cancer, Vol. 126, Issue 5, pp. 1263-74, (2010) (PubMed).: "An approach based on a genome-wide association study reveals candidate loci for narcolepsy." in: Human genetics, Vol. 128, Issue 4, pp. 433-41, (2010) (PubMed).
: "KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction." in: Biochemical and biophysical research communications, Vol. 351, Issue 1, pp. 216-22, (2006) (PubMed).
: "Transcriptional repression activity of PAX3 is modulated by competition between corepressor KAP1 and heterochromatin protein 1." in: Biochemical and biophysical research communications, Vol. 349, Issue 2, pp. 573-81, (2006) (PubMed).
: "Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP..." in: The Journal of biological chemistry, Vol. 280, Issue 17, pp. 17235-42, (2005) (PubMed).
: "Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant." in: Biochemical and biophysical research communications, Vol. 305, Issue 2, pp. 311-4, (2003) (PubMed).
: "Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression." in: Molecular and cellular biology, Vol. 20, Issue 5, pp. 1723-32, (2000) (PubMed).
: "Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma." in: Cancer research, Vol. 60, Issue 17, pp. 4697-700, (2000) (PubMed).
Synonyme und alternative Namen zu CDKN3
cyclin dependent kinase inhibitor 3 (CDKN3), cyclin-dependent kinase inhibitor 3 (CDKN3), cyclin-dependent kinase inhibitor 3 (cdkn3), cyclin-dependent kinase inhibitor 3 (Cdkn3), cyclin dependent kinase inhibitor 3 (Cdkn3), inhibitor/interactor with cyclin-dependent kinase (ICK6), 2410006H10Rik, CDI1, CDKN3, CIP2, inhibitor/interactor with cyclin-dependent kinase, K24G6.15, K24G6_15, KAP, KAP1, KIP-RELATED PROTEIN 3, KRP3Bezeichner auf Proteinebene für CDKN3
- CDK2-associated dual specificity phosphatase
- CDK2-associated dual-specificity phosphatase
- Cdk-associated protein phosphatase
- cyclin-dependent kinase interacting protein 2
- cyclin-dependent kinase interactor 1
- cyclin-dependent kinase-interacting protein 2
- kinase associated phosphatase
- kinase-associated phosphatase
- cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase)
- cyclin-dependent kinase inhibitor 3
- Kinase-associated phosphatase
- Inhibitor/interactor of CDK protein 6
- KIP-related protein 3
Sie sind hier:
